$LIPO

$0.00 +$0.00 (0.0%) Close

$LIPO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 4.6M shares outstanding

Who owns LIPO?

By type of holder

Institutions 0.0% Everyone else 100.0%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Concentration Top 2 holders own 9.1%

Jonathan H. Kaufman 4.6% · Michael B. Chancellor 4.5%

Institutional ownership

0.0%

0.0 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

by institutions in Q2 2026

New / sold out

0 / 0

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Lipella Pharmaceuticals Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2021–FY2024

+7.6%

+2.49% a year

Each share's claim on the business

−7.1%

shrank without buying or selling a share

Diluted shares, split-adjusted

How patient are the owners?

No 13F manager reports holding LIPO.

Super Investors

Investment managers reporting LIPO on Form 13F

No 13F manager reports holding LIPO yet.

Institutional Funds

Mutual funds and ETFs reporting LIPO on Form N-PORT; together they hold 0.3% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
FE Fidelity Extended Market Index Fund Fidelity Concord Street Trust	$16.6K	5.8K	0.13%	0.00%	May 31, 2025
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$10.8K	4.3K	0.09%	0.00%	March 31, 2025

Fidelity Extended Market Index Fund

Fidelity Concord Street Trust

Position value

$16.6K

% of company

0.13%

% of the fund

0.00%

As of

May 31, 2025

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$10.8K

% of company

0.09%

% of the fund

0.00%

As of

March 31, 2025

1 more funds behind a free account

See every fund holding Lipella Pharmaceuticals Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
JH Jonathan H. Kaufman 5%+ holder 13D · 4.9%	212.3K	4.59%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company4.590% Disclosed stake13D · 4.9% View the 13D/G filing →
MB Michael B. Chancellor 5%+ holder 13D · 4.8%	209.6K	4.54%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company4.540% Disclosed stake13D · 4.8% View the 13D/G filing →

Jonathan H. Kaufman

5%+ holder13D · 4.9%

212.3K

% of company

4.59%

Change vs last qtr

—

Held since

—

Michael B. Chancellor

5%+ holder13D · 4.8%

209.6K

% of company

4.54%

Change vs last qtr

—

Held since

—

Comments